Inovio Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Inovio Pharmaceuticals

08/08/2024 22:52

* Inovio Pharmaceuticals Inc  INO.OQ  reported a quarterly
adjusted loss of $1.19​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of $-1.56.  The mean expectation of six analysts
for the quarter was for a loss of $1.10 per share. Wall Street
expected results to range from $-1.28 to -94 cents per share.
    * Revenue fell 55.4% to $100.76 thousand from a year ago;
analysts
expected $121.50 thousand. 
    * Inovio Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.19​.
    * The company reported a quarterly loss of $32.24 million.
    * Inovio Pharmaceuticals Inc shares had risen by 6.3% this
quarter and gained 40.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 14.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Inovio
Pharmaceuticals Inc is $16.50 
This summary was machine generated from LSEG data August 8 at
09:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.10          -1.19          Missed
 Mar. 31 2024      -1.00          -1.31          Missed
 Dec. 31 2023      -1.27          -1.12          Beat
 Sep. 30 2023      -1.52          -1.56          Missed